Corporate reputation is at times mistakenly viewed as a soft asset, yet it holds clear bottom-line consequences. Following our rules for reputation can make the difference between a physician writing a script for your treatment — or not.
WE’s 2024 Brands in Motion health report, “Reputation Rules: Unlocking Physician Prescribing Power,” validates and builds on our survey findings from last year of a wider group of healthcare practitioners, which first revealed the direct connection between corporate reputation and prescribing decisions.
Lead with innovation
Highlight both the scientific and patient journey from molecule to medicine.
Treat physicians as partners
Companies must be transparent around pricing structures and access programs to win physicians over.
Capitalize on digital trends
Social media continues to rise as an important information channel.